1. Home
  2. Blog
  3. Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.

Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.

Friday, October 23rd 2015

Loeb S, Folkvaljon Y, Lambe M, Robinson D, Garmo H, Ingvar C, Stattin P. “Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.”  JAMA 2015; 313: 2449-55. PMID: 26103029.

Link: http://www.ncbi.nlm.nih.gov/pubmed/26103029

Comments are closed.